Evoke Pharma Reports Topline Results from EVK-001 Phase 3 Clinical Trial Read more about Evoke Pharma Reports Topline Results from EVK-001 Phase 3 Clinical Trial
Evoke Advances Commercial Preparations for EVK-001 with inVentiv Agreement Read more about Evoke Advances Commercial Preparations for EVK-001 with inVentiv Agreement
Evoke Completes Phase 3 Clinical Trial of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis Read more about Evoke Completes Phase 3 Clinical Trial of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis
Evoke Pharma Presents Data from Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016 Read more about Evoke Pharma Presents Data from Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016
Evoke Enters Exclusive Commercial Supply Agreement for Active Pharmaceutical Ingredient in EVK-001 Read more about Evoke Enters Exclusive Commercial Supply Agreement for Active Pharmaceutical Ingredient in EVK-001
Evoke Pharma Reports First Quarter 2016 Results Read more about Evoke Pharma Reports First Quarter 2016 Results
Evoke Pharma Schedules Webcast and Conference Call for First Quarter 2016 Financial Results Read more about Evoke Pharma Schedules Webcast and Conference Call for First Quarter 2016 Financial Results
Evoke Announces Timing of Phase 3 Results from its Recently Fully Enrolled Pivotal Clinical Trial of EVK-001 Read more about Evoke Announces Timing of Phase 3 Results from its Recently Fully Enrolled Pivotal Clinical Trial of EVK-001
Evoke Successfully Completes Phase 3 Clinical Trial Enrollment of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis Read more about Evoke Successfully Completes Phase 3 Clinical Trial Enrollment of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis
Evoke Pharma Reports Fourth Quarter and Year End 2015 Results Read more about Evoke Pharma Reports Fourth Quarter and Year End 2015 Results